In Melbourne via Wales
🖨 This paper brings together a wide range of findings that provide real world evidence to inform future directions for gNBS.
👉 www.nature.com/articles/s41...
1,000 babies
WGS using existing cards
600+ conditions
13 day TAT
16 diagnoses (vs 1 in std NBS)
High clinical impact
High parental acceptability
🖨 This paper brings together a wide range of findings that provide real world evidence to inform future directions for gNBS.
Our paper proposes how cultural adaptation in public health innovation can be enhanced by 5 imp sci approaches
I am grateful to kick off my PhD and have the wisdom of @stephaniebest.bsky.social Samantha Croy & Marlena Klaic lnkd.in/ggwBy9_h #equity #impsci
Our paper proposes how cultural adaptation in public health innovation can be enhanced by 5 imp sci approaches
I am grateful to kick off my PhD and have the wisdom of @stephaniebest.bsky.social Samantha Croy & Marlena Klaic lnkd.in/ggwBy9_h #equity #impsci
doi: 10.1186/s43058-024
Important for us to continue critiquing how we consider research outcomes.
@Zornitza and Marlena Klaic
doi: 10.1186/s43058-024
Important for us to continue critiquing how we consider research outcomes.
@Zornitza and Marlena Klaic
Congrats to @iliasgoranitis.bsky.social and @zornitza.bsky.social and team.
@ajhgnews.bsky.social
@iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social
#raredisease #genomics #healtheconomics
www.sciencedirect.com/science/arti...
Congrats to @iliasgoranitis.bsky.social and @zornitza.bsky.social and team.
Key lessons from #AustralianGenomics are highlighted in @natmedicine.bsky.social
@zornitza.bsky.social @stephaniebest.bsky.social
Key lessons from #AustralianGenomics are highlighted in @natmedicine.bsky.social
@zornitza.bsky.social @stephaniebest.bsky.social
Leadership, collaborative networks and a wide geographical reach are all critical.
Read more at the link below.
👉 rdcu.be/eeuAN
Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆
@stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
Leadership, collaborative networks and a wide geographical reach are all critical.
Read more at the link below.
📄Bi-allelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiency
This is the paper for you! rb.gy/h9nks7
We found
* 34 barriers
* 25 empirical and 10 complementary theoretical imp strategies
Lin Cheng, Kushani Jayasinghe, @zornitza.bsky.social @cathyquinlan.bsky.social Nathasha Kugenthiran
Melbourne Genomics
This is the paper for you! rb.gy/h9nks7
We found
* 34 barriers
* 25 empirical and 10 complementary theoretical imp strategies
Lin Cheng, Kushani Jayasinghe, @zornitza.bsky.social @cathyquinlan.bsky.social Nathasha Kugenthiran
Melbourne Genomics
📅 3rd March 2025
📍 @petermaccc.bsky.social & Zoom
Connect with experts, explore PRS research, & tackle key challenges in clinical implementation.
🔗 Register here: zoom.us/j/9882106217...
#genechat
Read more: www.australiangenomics.org.au/access-to-ge...
@stephaniebest.bsky.social @scasauria16.bsky.social
Read more: www.australiangenomics.org.au/access-to-ge...
@stephaniebest.bsky.social @scasauria16.bsky.social
Great team!
@zornitza.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @zoefehlberg.bsky.social
👉 www.valueinhealthjournal.com/article/S109...
👏 great collaboration @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @stephaniebest.bsky.social @zoefehlberg.bsky.social @ausgenomics.bsky.social
Great team!
@zornitza.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social @zoefehlberg.bsky.social
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility)
doi.org/10.1016/j.jv...
@zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
Then this is the paper for you! doi.org/10.1186/s430...
Led by @zoefehlberg.bsky.social & dream authorship team @zornitza.bsky.social & Marlena Klaic
Out now in @implementsci.bsky.social
#genomics, @ausgenomics.bsky.social
Then this is the paper for you! doi.org/10.1186/s430...
Led by @zoefehlberg.bsky.social & dream authorship team @zornitza.bsky.social & Marlena Klaic
Out now in @implementsci.bsky.social
#genomics, @ausgenomics.bsky.social
We explored the geographic distribution of rare disease #genomic testing across Australia 🧬. Take a peak!
doi.org/10.1038/s414...
We explored the geographic distribution of rare disease #genomic testing across Australia 🧬. Take a peak!
doi.org/10.1038/s414...
How do we best support choices when offering #genomic screening? @ausgenomics.bsky.social
Check out our 2-step model👇
doi.org/10.1016/j.gi...
Terrific collab @yvonnebombard.bsky.social & GeneticsAdviser! 🇨🇦🇦🇺 @genetic-fi.bsky.social @stephaniebest.bsky.social
How do we best support choices when offering #genomic screening? @ausgenomics.bsky.social
Check out our 2-step model👇
doi.org/10.1016/j.gi...
Terrific collab @yvonnebombard.bsky.social & GeneticsAdviser! 🇨🇦🇦🇺 @genetic-fi.bsky.social @stephaniebest.bsky.social
Ultra-rapid genomic testing in mito disease ⏱️🧬🇦🇺
👉 authors.elsevier.com/a/1kDPZ3vlFV...
Broad analysis and functional genomics for best outcomes 🏆
@ausgenomics.bsky.social @thorburnmito.bsky.social @mitochondrially.bsky.social @scott-lab-gmp.bsky.social
Ultra-rapid genomic testing in mito disease ⏱️🧬🇦🇺
👉 authors.elsevier.com/a/1kDPZ3vlFV...
Broad analysis and functional genomics for best outcomes 🏆
@ausgenomics.bsky.social @thorburnmito.bsky.social @mitochondrially.bsky.social @scott-lab-gmp.bsky.social
This is the paper for you.
Congratulations to @scasauria16.bsky.social for seeing this, long in the making, study to publication.
We explored the geographic distribution of rare disease #genomic testing across Australia 🧬. Take a peak!
doi.org/10.1038/s414...
This is the paper for you.
Congratulations to @scasauria16.bsky.social for seeing this, long in the making, study to publication.